CD4 and systemic lupus erythematosus: This mechanism achieves an inhibitory effect on CD4+ T cells and B cells, leading to a reduction in the production of anti-nuclear antibodies and the suppression of SLE immune inflammation-mediated damage to systemic tissues (154).